Prostate cancer

“Synthetic lethality” is where genetic mutations that normally don’t harm a cell become deadly when paired up. Now, scientists have found a way to use this to selectively kill off cancer caused by genetic mutations, without harming healthy cells.

Scientists are reporting promising findings from a prostate cancer trial where patients were administered a drug typically used to treat breast cancer, where it proved more effective than standard treatments at applying the brakes to the disease.

Two new diagnostic techniques hope to help catch the most aggressive forms of prostate cancer. One study measures gene expression in tumors to predict disease severity, while another details a new imaging technique to detect metastatic disease.

Two new studies are demonstrating the development of diagnostic tests to detect prostate cancer. The research presents a urine test that can detect the disease in its early stages and a blood test that may catch the cancer as it begins to metastasize.

Two new systematic reviews have concluded omega-3 supplements confer little protective benefit against either cardiovascular disease or cancer. The research builds on prior study suggesting fish oil is mostly useless if taken by healthy individuals.

A safer and less invasive treatment option for prostate cancer could soon be on the table, with a novel MRI-guided ultrasound technique eliminating significant cancers in 80 percent of subjects in a year-long study.

A potential new cancer diagnostics tool has emerged from the UK’s University of East Anglia (UEA), where scientists have developed a urine test for the home that can reveal prostate cancers in need of treatment.

In preclinical tests, scientists at Wistar Institute have developed a molecule that disrupts a protein complex vital to cancer cell survival.

Scientists have developed a new prostate cancer blood test that promises significant increases in accuracy compared to current blood tests.

A study has homed in on compounds in coffee that may inhibit the growth of prostate cancer. The research has only been shown in animal models at this point but the discovery may explain why several observational studies found male coffee drinkers often suffer from lower rates of prostate cancer.

​Researchers at the Roswell Park Comprehensive Cancer Center have discovered that a newly identified mutation on the X-chromosome, passed down from the father, may be linked to an earlier onset of ovarian cancer in women and higher rates of prostate cancer in men.

A team from the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) has been studying the mechanisms behind the metastatic progression of prostate cancer. They've found that a high-fat diet could play a major role in promoting metastasis of what is generally an "indolent" disease.